PCOT for Outpatients With Acute Respiratory Tract Infection at Risk of Severe Disease in Primary Healthcare

ConditionAcute Respiratory Tract Infection

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorCapital Medical University

About this trial

This study aims to evaluate the clinical value of point-of-care multiplex PCR testing (POCT) in guiding early diagnosis and target treatment for acute respiratory infections in primary healthcare settings.

Eligibility criteria

Qualifiers

Onset time<=7 days;

First visit;

Age>=18 years old;

Patients with acute upper respiratory tract infection with severe high-risk factors, or patients with acute lower respiratory tract infection;

Disqualifiers

The doctor judges that the disease is serious and requires hospitalization;

New unclear consciousness;

Respiratory rate>=30 beats/min;

Hypoxemia or respiratory failure;

Trial design

Treatments tested in this trial

point-of-care multiplex PCR test

Treatment groups

16,868 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Capital Medical University

Lead sponsor

Source ClinicalTrials.gov